Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit $100 per Ounce?

How Would a New BRICS Currency Affect the US Dollar? (Updated 2025)

13 Canadian Crypto ETFs (Updated 2025)

10 Top Oil-producing Countries

Uranium Stocks: 5 Biggest Companies

Where Does Tesla Get its Lithium?

Will Trump Bring Back the Gold Standard?

Can You Invest in Neuralink?

When is the Starlink IPO Date and Can You Invest?

Trending Press Releases

Critical Metals Corp. Enters Into Share Subscription Facility For Up To US$125.0M In Transaction Funding

Stardust Power Inc. Announces Pricing of $5.75 Million Public Offering

Greenland Tanbreez Project Maiden Drill Results

CONNEQT App Launches in USA as Pulse Deliveries Commence

Athena Reports High-Grade Silver, up to 6,630 g/t, from Newly Completed Prospecting Program at Excelsior Springs, Nevada

Quarterly Activities/Appendix 4C Cash Flow Report

More Press Releases
Trending Companies

First Helium

HELI:CA

Radisson Mining Resources

RDS:CC

Hempalta

HEMP:CC

Cygnus Metals

CYG:CC
More Companies
Trending Reports

2025 World Cleantech Outlook Report

Silver Price Forecast - What Happened And Where Do We Go From Here?

Rare Earths Outlook Report

2025 Uranium Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

tsx:crdl

LATEST ARTICLES
Cardiol Therapeutics to Advance CardiolRx into a Late-Stage Trial in Patients with Recurrent Pericarditis
Biotech Investing

Cardiol Therapeutics to Advance CardiolRx into a Late-Stage Trial in Patients with Recurrent Pericarditis

Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option
Biotech Investing

Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option

Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares
Biotech Investing

Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares

Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares
Biotech Investing

Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares

Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares
Biotech Investing

Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares

Cardiol Therapeutics (TSX:CRDL)
Pharmaceutical Investing

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis

Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024
Biotech Investing

Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024

Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders
Pharmaceutical Investing

Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders

Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT
Pharmaceutical Investing

Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT

Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx for Recurrent Pericarditis
Pharmaceutical Investing

Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx for Recurrent Pericarditis

Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024
Pharmaceutical Investing

Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024

Cardiol Therapeutics Announces Year-End 2023 Update on Operations
Pharmaceutical Investing

Cardiol Therapeutics Announces Year-End 2023 Update on Operations

Latest News

More News